Now showing items 21-30 of 470
Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program
(National Academy of SciencesWiley Periodicals, Inc., 2014-03-15)
The impact of health insurance on cancer care in disadvantaged communities
(American Cancer SocietyWiley Periodicals, Inc., 2017-04-01)
Racial/ethnic differences in adequacy of information and support for women with breast cancer
(Wiley Subscription Services, Inc., A Wiley Company, 2008-09-01)
BACKGROUND. Providing breast cancer patients with needed information and support is an essential component of quality care. This study investigated racial/ethnic variations in the information received and in the availability ...
Decision‐support networks of women newly diagnosed with breast cancer
(John Wiley & Sons, 2017-10-15)
Understanding the engagement of key decision support persons in patient decision making around breast cancer treatment
(Wiley Periodicals, Inc.National Academy of Sciences, 2019-05-15)
TMPRSS2â ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer
(Wiley Periodicals, Inc.Elsevier, 2017-03)
Risk perception and concern among brothers of men with prostate carcinoma
(Wiley Subscription Services, Inc., A Wiley Company, 2004-04-01)
BACKGROUND It is important for clinicians, researchers, and others who shape public health policy to understand the demographic correlates and psychologic factors that drive health behaviors, such as screening for early ...
Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy
(Wiley Subscription Services, Inc., A Wiley Company, 2009-09-15)
BACKGROUND: In a retrospective study of Southwestern Oncology Group (SWOG)-S8710/INT-0080 (radical cystectomy [RC] alone vs 3 cycles of neoadjuvant chemotherapy [NC] with methotrexate, vinblastine, doxorubicin, and cisplatin ...
Can true papillary neoplasms of breast and their mimickers be accurately classified by cytology?
(Wiley Subscription Services, Inc., A Wiley Company, 2002-04-25)
BACKGROUND The cytologic accuracy in assessing malignancy in papillary breast neoplasms (PBNs) is controversial. This is further complicated by overlapping features observed in other breast lesions that produce papillary-like ...